KHAN, K. . Pioglitazone for Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes: A Meta-Analysis. International Journal of Medical and Biomedical Studies, [S. l.], v. 9, n. 1, p. 259–264, 2025. DOI: 10.32553/ijmbs.v9i1.3091. Disponível em: https://www.ijmbs.info/index.php/ijmbs/article/view/3091. Acesso em: 27 apr. 2026.